Cellectis Market Cap

Cellectis has a market cap or net worth of €228.55 million as of March 6, 2026. Its market cap has increased by 121.19% in one year.

Market Cap

228.55M

Enterprise Value

259.75M

Revenue

70.36M

Ranking

n/a

PE Ratio

n/a

Stock Price

€3.16

Market Cap Chart

Since February 7, 2007, Cellectis's market cap has increased from 100.59M to 228.55M, an increase of 127.20%. That is a compound annual growth rate of 4.39%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	228.55M	-24.67%
Dec 31, 2025	303.40M	158.68%
Dec 31, 2024	117.29M	-40.86%
Dec 29, 2023	198.32M	118.98%
Dec 30, 2022	90.57M	-73.23%
Dec 31, 2021	338.35M	-67.37%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Transgene	233.30M
Genfit	435.46M
MaaT Pharma	131.34M
Innate Pharma	128.78M
Sensorion	128.25M
Adocia	126.57M
ABIONYX Pharma	114.83M
OSE Immunotherapeutics	91.03M

Market Cap Rankings